China Vacuum Blood Collection Device Industry Report, 2017-2021
  • Sep.2017
  • Hard Copy
  • USD $2,600
  • Pages:100
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: ZLC057
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,800
  • Hard Copy + Single User License
  • USD $2,800

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awareness of health and larger health expenditure, the spending on examination also increases, so does the demand for vacuum blood collection tubes. The country’s consumption of vacuum blood collection tubes has shown an AAGR of over 10% between 2009 and 2016, reaching 5.973 billion pieces in 2016.

There have been 115 vacuum blood collection tube producers in China by Sept 20, 2017, led by Guangzhou Improve Medical Instruments, Sanli Group, Zhejiang Gongdong Medical Technology, Chengdu Rich Science Industry, Jiangsu KANGJIAN Medical Apparatus, Weigao Group and Lingen Precision Medical Products. In addition, the vast development potential has attracted foreign enterprises like BD, Sekisui Medical, and Greiner into China.

Local Chinese enterprises occupy primarily the mid and low-end vacuum blood collection market due to relatively outdated technologies, while foreign players still seize the high-end market. In 2016, the Chinese vacuum blood collection tube market was dominated by BD, Guangzhou Improve Medical Instruments, Sanli Group and Zhejiang Gongdong Medical Technology, holding a combined 42.3% market share.


In the coming years, the Chinese vacuum blood collection market will be characterized as follows:

1. Demand for vacuum blood collection tubes will grow steadily.
Authorities including the State Council have introduced policies to provide strong support for medical equipment industry in recent years. As a branch of the medical equipment industry, vacuum blood collection equipment will also benefit. Driven by downstream demand and favorable policies, the country’s demand for vacuum blood collection tubes is expected to maintain a higher growth rate over the next five years, hitting 10.677 billion pieces in 2021.

2. Vacuum blood collection device industry will become more highly concentrated.
Up to 115 vacuum blood collection tube manufacturers have caused severe overcapacity. Moreover, engagement of listed companies like Hunan China Sun and Jiangsu Yuyue Medical Equipment & Supply has intensified competition across the sector. However, as the country strengthens its supervision over the industry, the space for small companies will be squeezed, resulting in a gradual decrease in number of manufacturers and a higher market concentration.

3. Market share of foreign companies will decline.
Some local companies have maintained stable spending on R&D in recent years, seeking to narrow the gap with foreign peers. Guangzhou Improve Medical Instruments, Lingen Precision Medical Products and Weigao Group have broken monopoly of foreign players in manufacturing of high-end blood collection tubes like plasma preparation tube for nucleic acid test. Meanwhile, foreign companies represented by BD have frequently recalled their products due to quality problems, producing an adverse effect on their development in China. Under such circumstance, foreign players will suffer a gradual decline in market share.

China Vacuum Blood Collection Device Industry Report, 2017-2021 focuses on the followings:
20120114.gifOverview of global vacuum blood collection device industry (development course and status quo, etc.);
20120114.gifVacuum blood collection equipment industry in China (development environment, status quo, relevant policies, competitive landscape, import & export, development trends, etc.);
20120114.gif13 domestic and 4 foreign vacuum blood collection-related enterprises (operation, revenue structure, vacuum blood collection business, etc.)

1 Overview
1.1 Definition
1.2 Classification

2 Overview of Global Vacuum Blood Collection Device Industry
2.1 Development Course
2.2 Status Quo

3 Development of China Vacuum Blood Collection Device Industry
3.1 Development Environment
3.1.1 Economic Environment
3.1.2 Per Capita Disposable Income
3.1.3 Number of Medical Institutions
3.1.4 Clinic Visits
3.1.5 Health Expenditure
3.1.6 Aging 
3.1.7 Revenue of Clinical Laboratories
3.2 Current Development
3.3 Policies
3.4 Entry Barriers
3.5 Competitive Landscape
3.6 Import & Export
3.6.1 Import
3.6.2 Export
3.7 Development trends
3.7.1 National Industrial Policy Provides Strong Support
3.7.2 The Demand in Medical Industry Keeps Growing and Consumption Market Has Broad Prospects
3.7.3 Market Concentration Improves
3.7.4 Technical Level of the Industry Rises Steadily
3.7.5 Foreign Companies See a Decreasing Market Share

4 Major Chinese Companies
4.1 Guangzhou Improve Medical Instruments Co., Ltd.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D and Investment
4.1.6 Vacuum Blood Collection Business
4.1.7 Growth Prediction
4.2 Chengdu Rich Science Industry Co., Ltd.
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 R&D and Investment
4.2.6 Vacuum Blood Collection Business
4.2.7 Growth Prediction
4.3 Hunan China Sun Pharmaceutical Machinery Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Vacuum Blood Collection Business
4.4 Weigao Group
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 Vacuum Blood Collection Business
4.5 Lingen Precision Medical Products Co., Ltd.
4.5.1 Profile
4.5.2 Vacuum Blood Collection Business
4.5.3 Developments
4.6 Liuyang SANLI Medical Technology Development
4.6.1 Profile
4.6.2 Vacuum Blood Collection Business
4.7 Sekisui Medical Technology (China) Co., Ltd.
4.7.1 Profile
4.7.2 Vacuum Blood Collection Business
4.7.3 Developments
4.8 Shanghai Kindly Enterprise Development Group
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 Vacuum Blood Collection Business
4.9 Weihai Hongyu Medical Devices
4.9.1 Profile
4.9.2 Vacuum Blood Collection Business
4.10 Zhejiang Gongdong Medical Technology Co., Ltd.
4.10.1 Profile
4.10.2 Vacuum Blood Collection Business
4.11 Hebei Xinle Sci & Tech Co., Ltd.
4.11.1 Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Gross Margin
4.11.5 R&D and Investment
4.11.6 Vacuum Blood Collection Business
4.11.7 Growth Prediction
4.12 Shandong Yaohua Medical Instrument Corporation
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Gross Margin
4.12.5 R&D and Investment
4.12.6 Major Customers
4.12.7 Vacuum Blood Collection Business
4.12.8 Growth Prediction
4.13 Jiangsu KANGJIAN Medical Apparatus Co., Ltd.
4.13.1 Profile
4.13.2 Vacuum Blood Collection Business

5 Major Overseas Companies
5.1 BD (Becton, Dickinson and Company)
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Vacuum Blood Collection Business
5.1.6 Development in China
5.2 Terumo
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Vacuum Blood Collection Business
5.2.5 Development in China
5.3 Nipro
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Vacuum Blood Collection Business
5.3.5 Development in China
5.4 Greiner Bio One
5.4.1 Profile
5.4.2 Operation
5.4.3 Vacuum Blood Collection Business
5.4.4 Development in China
Classification and Applications of Vacuum Blood Collection Tubes
Classification of Vacuum Blood Collection Tubes (by Cranial Color)
Development Characteristics of Vacuum Blood Collection System by Generation
Performance of Vacuum Blood Collection System by Generation
Global Consumption of Vacuum Blood Collection Tubes, 2008-2016
China’s GDP, 2012-2017
Residents’ Per-capita Disposable Income and YoY Growth in China, 2011-2016
Number of Medical and Healthcare Institutions in China, 2015-2017
Number of Hospitals in China, 2009-2017
Number of Hospitals in China by Economic Type, 2009-2017 
Clinic Visits of Medical Institutions in China, 2015-2017
Clinic Visits of Hospitals in China, 2009-2017
Clinic Visits of Hospitals in China by Economic Type, 2012-2017
Health Expenditure in China, 2010-2016
Health Expenditure in China, 2016-2021E
Population Aged over 60 in China, 2009-2021E
Public Hospitals’ Inspection Revenue and % of Total Inspection Revenue in China, 2010-2016
Public Hospitals’ Inspection Revenue and % of Total Inspection Revenue in China, 2016-2021E
Vacuum Blood Collection Tube Consumption and YoY Growth in China, 2009-2016
Polices Concerning Medical Equipment Industry in China, 2007-2017
Vacuum Blood Collection Tube Market Pattern in China
Vacuum Blood Collection Tube Market Share in China, 2016
Vacuum Blood Collection Needle Market Pattern in China
Vacuum Blood Collection Revenue of Major Vacuum Blood Collection System Companies in China, 2014-2017
Import Volume and Value of Other Needles, Catheters, Cannulas and Similar Supplies in China, 2012-2017
TOP10 Import Sources of Other Needles, Catheters, Cannulas and Similar Supplies in China by Import Volume, Jan-Jul 2017 
Export Volume and Value of Other Needles, Catheters, Cannulas and Similar Supplies in China, 2012-2017
TOP10 Export Destinations of Other Needles, Catheters, Cannulas and Similar Supplies in China by Export Volume, Jan-Jul 2017
Revenue and Gross Industrial Output Value of Medical Equipment Industry in China, 2008-2016
Consumption of Vacuum Blood Collection Tubes and YoY Growth in China, 2016-2021E
Cases of Listed Companies’ Layout in Vacuum Blood Collection Device Industry in China 
R&D Costs of Major Vacuum Blood Collection Device Companies in China, 2014-2017
Main Products and Application of Guangzhou Improve Medical Instruments
Revenue and Net Income of Guangzhou Improve Medical Instruments, 2013-2017
Revenue Breakdown of Guangzhou Improve Medical Instruments by Product, 2014-2017
Revenue Structure of Guangzhou Improve Medical Instruments by Product, 2014-2017
Gross Margin of Guangzhou Improve Medical Instruments by Product, 2014-2017
Guangzhou Improve Medical Instruments’ R&D Costs and % of Total Revenue, 2013-2017
Output, Sales Volume and Inventory of Guangzhou Improve Medical Instruments’ Vacuum Blood Collection Systems, 2013-2016
Guangzhou Improve Medical Instruments’ Revenue from Vacuum Blood Collection Systems and % of Total Revenue, 2014-2017
Revenue and Net Income of Guangzhou Improve Medical Instruments, 2016-2021E
Revenue and Net Income of Chengdu Rich Science Industry, 2013-2017
Revenue Breakdown of Chengdu Rich Science Industry by Product, 2013-2017
Revenue Structure of Chengdu Rich Science Industry by Product, 2013-2017
Revenue Breakdown of Chengdu Rich Science Industry by Region, 2013-2017
Revenue Structure of Chengdu Rich Science Industry by Region, 2013-2017
Gross Margin of Chengdu Rich Science Industry, 2013-2017
Chengdu Rich Science Industry’s R&D Costs and % of Total Revenue, 2013-2017
Chengdu Rich Science Industry’s Revenue from Vacuum Blood Collection Business and % of Total Revenue, 2013-2017
Revenue and Net Income of Chengdu Rich Science Industry, 2016-2021E
Revenue and Net Income of Hunan China Sun Pharmaceutical Machinery, 2013-2017
Revenue Breakdown of Hunan China Sun Pharmaceutical Machinery by Business, 2014-2016
Revenue Structure of Hunan China Sun Pharmaceutical Machinery by Business, 2014-2016
Gross Margin of Hunan China Sun Pharmaceutical Machinery by Business, 2014-2016
Weigao Group’s Product Categories and Main Products
Revenue and Net Income of Weigao Group, 2004-2017
Revenue Breakdown of Weigao Group by Product, 2014-2017
Revenue Structure of Weigao Group by Product, 2014-2017
Gross Margin of Weigao Group, 2014-2017
Weigao Group’s Revenue from Vacuum Blood Collection Products, 2014-2017
Equity Structure of Lingen Precision Medical Products
Main Special-purpose Vacuum Blood Collection Tubes of Lingen Precision Medical Products
Vacuum Blood Collection Products of Sekisui Medical Technology (China)
Revenue and Net Income of Shanghai Kindly Enterprise Development Group, 2013-2017
Revenue Breakdown of Shanghai Kindly Enterprise Development Group by Product, 2014-2016
Revenue Structure of Shanghai Kindly Enterprise Development Group by Product, 2014-2016
Gross Margin of Shanghai Kindly Enterprise Development Group by Product, 2014-2016
Vacuum Blood Collection Tubes of Weihai Hongyu Medical Devices 
Blood Collection Needles of Weihai Hongyu Medical Devices
Revenue and Net Income of Hebei Xinle Sci & Tech, 2013-2017
Revenue Breakdown of Hebei Xinle Sci & Tech by Region, 2014-2016
Revenue Structure of Hebei Xinle Sci & Tech by Region, 2014-2016
Gross Margin of Hebei Xinle Sci & Tech, 2013-2017
Hebei Xinle Sci & Tech’s R&D Costs and % of Total Revenue, 2013-2017
Revenue and Net Income of Hebei Xinle Sci & Tech, 2016-2021E
Main Products of Shandong Yaohua Medical Instrument
Revenue and Net Income of Shandong Yaohua Medical Instrument, 2014-2017
Revenue Breakdown of Shandong Yaohua Medical Instrument by Product, 2014-2016
Revenue Structure of Shandong Yaohua Medical Instrument by Product, 2014-2016
Gross Margin of Shandong Yaohua Medical Instrument, 2014-2017
Shandong Yaohua Medical Instrument’s R&D Costs and % of Total Revenue, 2014-2017
Shandong Yaohua Medical Instrument’s Revenue from TOP5 Clients and % of Total Revenue, 2015-2017
Shandong Yaohua Medical Instrument’s Revenue from Vacuum Blood Collection Business and % of Total Revenue, 2014-2016
Revenue and Net Income of Shandong Yaohua Medical Instrument, 2016-2021E
Main Vacuum Blood Collection Products of Jiangsu KANGJIAN Medical Apparatus
BD’s Revenue and Net Income, FY2013-FY2017
BD’s Revenue Breakdown by Business, FY2013-FY2017
BD’s Revenue Structure by Business, FY2013-FY2017
BD’s Gross Margin, FY2013-FY2016
BD’s Revenue from Vacuum Blood Collection Business and % of Total Revenue, FY2013-FY2017
BD’s Main Business in China
Terumo’s Revenue and Net Income, FY2012-FY2016
Terumo’s Revenue Breakdown by Business, FY2012-FY2016
Terumo’s Revenue Structure by Business, FY2012-FY2016
Terumo’s Revenue from Blood Management Division and % of Total Revenue, FY2012-FY2016
Terumo's Subsidiaries in China and Main Business
Terumo's Layout in China
Nipro’s Revenue and Net Income, FY2013-FY2017
Nipro’s Revenue Breakdown by Business, FY2014-FY2017
Nipro’s Revenue Structure by Business, FY2014-FY2017
Nipro’s Revenue Breakdown by Region, FY2014-FY2017
Nipro’s Revenue Structure by Region, FY2014-FY2017
Nipro’s Revenue from Medical Business and % of Total Revenue, FY2014-FY2017
Nipro's Major Subsidiaries in China and Business
Presence of Greiner Bio One’s Production Bases
Greiner Bio One’s Revenue and YoY Growth, FY2013-FY2016
Greiner Bio One’s Vacuum Blood Collection Products  

China Animal Vaccine Industry Report, 2019-2025

Chinese animal vaccine industry showed a CAGR of 8% between 2013 and 2017, but it was depressed by the outbreak of African Swine Fever in 2018 with the market size edging down 2.5% on an annualized ba...

China Blood Product Industry Report, 2020-2026

With the dynamic adjustment in the catalog of medicines covered by national medical insurance system, the scope of clinical use of almost all blood products grows tremendously, so does the reimburseme...

China Vacuum Blood Collection Device Industry Report, 2019-2025

As laboratory medicine advances, favorable polices are issued and people live a better life and care more about their health, vacuum blood collection systems get increasingly used. In 2018, global vac...

China Human Vaccine Industry Report, 2019-2025

China has been the world’s biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseas...

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号